Long term graft and patient outcomes in highly-HLA sensitized (HS) patients desensitized with high dose (HD) IVIG

被引：0
|
作者：
Peng, Alice [1 ]
Vo, Ashley [1 ]
Villicana, Rafael [1 ]
Lee, Richard [1 ]
Dafoe, Donald [1 ]
Reinsmoen, Nancy [1 ]
Skinner, Edwina [1 ]
Jordan, Stanley [1 ]
机构：
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
下载
收藏
页码：352 / 352
页数：1
相关论文
共 50 条
  • [31] Monitoring T cell ATP levels in highly sensitized (HS) kidney allograft recipients: Assessment of responses to IVIG therapy (Rx) and correlation with long-term outcomes
    Toyoda, Mieko
    Vo, Ashley
    Puliyanda, Dechu
    Pao, Andy
    Petrosyan, Anna
    Peng, Alice
    Bunnapradist, Mike
    Jordan, Stanley C.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S101 - S101
  • [32] Influence of a Sensitized Patient Program and Clinic On Kidney Transplant Rates and Outcomes in Highly HLA-Sensitized Patients
    Shields, A.
    Cuffy, M.
    Ejaz, N.
    Barker, M.
    Brown, E.
    Girnita, A.
    Cardi, M.
    Abu Jawdeh, B.
    Mogilishetty, G.
    Woodle, E.
    TRANSPLANTATION, 2014, 98 : 592 - 593
  • [33] Influence of a Sensitized Patient Program and Clinic On Kidney Transplant Rates and Outcomes in Highly HLA-Sensitized Patients
    Shields, A.
    Cuffy, M.
    Ejaz, N.
    Barker, M.
    Brown, E.
    Girnita, A.
    Cardi, M.
    Abu Jawdeh, B.
    Mogilishetty, G.
    Woodle, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 592 - 593
  • [34] Long Term (5-Year) Outcomes Using Subcutaneous Alemtuzumab for Induction in Highly-HLA-Sensitized (HS) Kidney Transplant Recipients.
    Chang, G.
    Vo, A.
    Choi, J.
    Kahwaji, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 429 - 429
  • [35] Impact of De Novo DSA (DnDSA) on Outcomes in HLA-Sensitized (HS) Patients Transplanted after IVIG plus Rituximab Desensitization (DES).
    Vo, A.
    Aubert, O.
    Edmund, H.
    Peng, A.
    Najjar, R.
    Supreet, S.
    Choi, J.
    Lim, K.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 516 - 516
  • [36] Clazakizumab® (anti-il-6) Desensitization in Highly-HLA Sensitized Patients Awaiting Kidney Transplant (nct03380962): Long-Term Follow Up.
    Vo, A.
    Tang, J.
    Ammerman, N.
    Huang, E.
    Zhang, X.
    Haas, M.
    Peng, A.
    Najjar, R.
    Williamson, S.
    Meyers, C.
    Sethi, S.
    Lim, K.
    Gillespie, M.
    Badash, N.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 508 - 508
  • [37] A phase I/II trial to investigate the safety and efficacy of rituxan® and intravenous garnmaglobulin (IVIG) as agents to desensitize highly-HLA sensitized dialysis patients awaiting kidney transplantation.
    Vo, Ashley A.
    Toyoda, Mieko
    Wang, Jennifer
    Lukovsky, Marina
    Peng, Alice
    Villicana, Rafael
    Dafoe, Don
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 158 - 158
  • [38] Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients
    Kahwaji, Joseph
    Barker, Eva
    Pepkowitz, Sam
    Klapper, Ellen
    Villicana, Rafael
    Peng, Alice
    Chang, Robert
    Jordan, Stanley C.
    Vo, Ashley A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (12): : 1993 - 1997
  • [39] Novel mechanism of action of intravenous immunoglobulin (IVIg): Anti-HLA class I antibodies in IVIg neutralize HLA class I-like anti-idiotypic antibodies (anti-ids) in the sera of highly sensitized (HS) patients
    Cardella, Carl J.
    Hack, Nashrudeen
    Angra, Sarita
    McKnight, Theresa
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 574 - 574
  • [40] Determining the optimal interval between consecutive high dose IVIG administration pre-transplantation facilitated successful heart transplantation in a highly sensitized patient
    Dev, Sandesh
    Cotts, William
    McGee, Edwin
    Friedewald, John
    Buckingham, Marguerite
    Tambur, Anat R.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S47 - S47
12345